Therapeutic oligonucleotides : (Record no. 390809)

000 -LEADER
fixed length control field 06959cam a2200769Ia 4500
001 - CONTROL NUMBER
control field ocn746342570
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200626150113.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr un|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 110811s2011 nyua ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency CUV
Language of cataloging eng
Description conventions pn
Transcribing agency CUV
Modifying agency CUV
-- DKDLA
-- OCLCO
-- OCLCQ
-- VT2
-- OCLCA
-- UBY
-- NUI
-- OCLCF
-- VVL
-- OCLCQ
-- YDXCP
-- EUW
-- OCLCQ
-- CAUOI
-- OCLCA
-- OCLCQ
-- LIP
-- ESU
-- OCLCO
-- OCLCA
-- BUF
-- OCLCO
-- OCLCQ
-- CASUM
-- U3W
-- OCLCO
-- AU@
-- OCLCO
-- OCLCQ
-- WURST
-- OCLCA
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 015804810
Source Uk
019 ## -
-- 771205370
-- 858048123
-- 859577484
-- 864812561
-- 889153375
-- 964877487
-- 967628063
-- 990736402
-- 1005777759
-- 1027488345
-- 1058380646
-- 1081258766
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781617791888
Qualifying information (e-ISBN)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1617791881
Qualifying information (e-ISBN)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781617791871
Qualifying information (p-ISBN)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 1617791873
Qualifying information (p-ISBN)
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-61779-188-8
Source of number or code doi
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)746342570
Canceled/invalid control number (OCoLC)771205370
-- (OCoLC)858048123
-- (OCoLC)859577484
-- (OCoLC)864812561
-- (OCoLC)889153375
-- (OCoLC)964877487
-- (OCoLC)967628063
-- (OCoLC)990736402
-- (OCoLC)1005777759
-- (OCoLC)1027488345
-- (OCoLC)1058380646
-- (OCoLC)1081258766
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QH345
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number W1
Item number ME9616J v.764 2011
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QU 25
072 #7 - SUBJECT CATEGORY CODE
Subject category code PSB
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI007000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 572.8/633
Edition number 23
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Therapeutic oligonucleotides :
Remainder of title methods and protocols /
Statement of responsibility, etc. edited by John Goodchild.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. New York :
Name of publisher, distributor, etc. Humana Press :
-- Springer,
Date of publication, distribution, etc. ©2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xi, 340 pages) :
Other physical details illustrations
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Source rda
490 1# - SERIES STATEMENT
Series statement Methods in molecular biology,
International Standard Serial Number 1064-3745 ;
Volume/sequential designation 764
490 1# - SERIES STATEMENT
Series statement Springer protocols
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 00 - FORMATTED CONTENTS NOTE
Title Therapeutic oligonucleotides /
Statement of responsibility John Goodchild --
Title Dinucleotides containing 3-S-phosphorothiolate linkages /
Statement of responsibility James W. Gaynor and Richard Cosstick --
Title 2-O,4-C-methyleneoxymethylene bridged nucleic acids (2,4-BNACOC) /
Statement of responsibility Yoshiyuki Hari [and others] --
Title Non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery /
Statement of responsibility Laurence Crombez [and others] --
Title Cell-penetrating peptides-based strategies for the delivery of splice redirecting antisense oligonucleotides /
Statement of responsibility Samir El Andaloussi [and others] --
Title Nanoparticle for tumor targeted delivery of oligomers /
Statement of responsibility Xinrong Liu, Yi Wang, and Donald J. Hnatowich --
Title Light-directed delivery of nucleic acids /
Statement of responsibility Sigurd Bøe [and others] --
Title Antibody targeted siRNA delivery /
Statement of responsibility Masoud M. Toloue and Lance P. Ford --
Title Aptamer-drug conjugation for targeted tumor cell therapy /
Statement of responsibility Michael J. Donovan [and others] --
Title Five-step process for screening antisense compounds for efficacy: gene target IL-12Rb2 /
Statement of responsibility Nikki B. Marshall, Laura L. Hauck, and Dan V. Mourich --
Title Diverse small non-coding RNAs in RNA interference pathways /
Statement of responsibility Liande Li and Yi Liu --
Title Quantification of siRNAs in vitro and in vivo /
Statement of responsibility Angie Cheng, Alexander V. Vlassov, and Susan Magdaleno --
Title Optimization of transfection conditions and analysis of siRNA potency using real-time PCR /
Statement of responsibility Angie Cheng, Susan Magdaleno, and Alexander V. Vlassov --
Title siRNA knockdown of gene expression in endothelial cells /
Statement of responsibility Emily Dennstedt and Brad Bryan --
Title Using RNA interference in Schistosoma mansoni /
Statement of responsibility Rita Bhardwaj, Greice Krautz-Peterson, and Patrick J. Skelly --
Title Performing the labeled microRNA pull-down (LAMP) assay system : an experimental approach for high-throughput identification of microRNA-target mRNAs /
Statement of responsibility Ren-Jun Hsu and Huai-Jen Tsai --
Title Synthesis, purification, and characterization of oligoribonucleotides that act as agonists of TLR7 and/or TLR8 /
Statement of responsibility Tao Lan and Ekambar R. Kandimalla --
Title Synthesis, purification, and characterization of immune-modulatory oligodeoxynucleotides that act as agonists of toll-like receptor 9 /
Statement of responsibility Mallikarjuna Reddy Putta, Dong Yu, and Ekambar R. Kandimalla --
Title Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions /
Statement of responsibility Carmelo Di Primo, Eric Dausse, and Jean-Jacques Toulme --
Title Practical considerations for analyzing antigene RNAs (agRNAs) : RNA immunoprecipitation of argonaute protein /
Statement of responsibility Jacob C. Schwartz and David R. Corey --
Title Inhibition of human papillomavirus expression using DNAzymes /
Statement of responsibility Maria Luisa Benitez-Hess, Pablo Reyes-Gutierrez, and Luis Marat Alvarez-Salas.
520 ## - SUMMARY, ETC.
Summary, etc. The field of oligonucleotide therapeutics research is ripe with the prospect of new discoveries. In Therapeutic Oligonucleotides: Methods and Protocols, a selection of established and emerging methods for the application of oligonucleotides as therapeutics are presented, all providing the tools needed to inspire great changes in the field. Divided into twenty-one chapters, this detailed volume meticulously describes vital protocols for optimizing and improving cell uptake, such as photochemical internalization, modified cell penetrating peptides, antibody conjugates, and nanoparticles. Other chapters address quantitation of RNA therapeutics in cells, assaying gene knockdown, selecting the best target site and synthesis of various modified oligonucleotides. Written in the successful Methods in Molecular Biology"!series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and easily accessible, Therapeutic Oligonucleotides: Methods and Protocols serves as a timely resource for both professionals and novices pursuing research in this exciting and pioneering field.
546 ## - LANGUAGE NOTE
Language note English.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oligonucleotides
General subdivision Therapeutic use.
9 (RLIN) 87237
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Polynucleotides.
9 (RLIN) 83858
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nucleotides.
9 (RLIN) 83859
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Nucleic Acids, Nucleotides, and Nucleosides
9 (RLIN) 79966
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Chemicals and Drugs
9 (RLIN) 13222
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oligonucleotides.
9 (RLIN) 83856
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oligonucleotides
General subdivision Therapeutic use.
Source of heading or term fast
Authority record control number (OCoLC)fst01045458
9 (RLIN) 87237
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term levenswetenschappen
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term life sciences
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term biochemie
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term biochemistry
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term nucleic acids
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term chemie
653 00 - INDEX TERM--UNCONTROLLED
Uncontrolled term chemistry
653 10 - INDEX TERM--UNCONTROLLED
Uncontrolled term Biology (General)
653 10 - INDEX TERM--UNCONTROLLED
Uncontrolled term Biologie (algemeen)
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 396
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Goodchild, John,
Titles and other words associated with a name chemist.
9 (RLIN) 87238
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Therapeutic oligonucleotides.
Place, publisher, and date of publication New York : Humana Press ; Springer, ©2011
International Standard Book Number 1617791873
Record control number (DLC) 2011931964
-- (OCoLC)728580587
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in molecular biology (Clifton, N.J.) ;
Volume number/sequential designation v. 764.
9 (RLIN) 87239
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Springer protocols (Series)
9 (RLIN) 80328
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://link-springer-com.libraryproxy.ist.ac.at/10.1007/978-1-61779-188-8">https://link-springer-com.libraryproxy.ist.ac.at/10.1007/978-1-61779-188-8</a>
938 ## -
-- YBP Library Services
-- YANK
-- 7476222
994 ## -
-- 92
-- ATIST
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Permanent Location Current Location Date acquired Date last seen Price effective from Koha item type
  Not Lost     EBook e-Library e-Library 2020-06-26 2020-06-26 2020-06-26 eBook

Powered by Koha